Jeffrey J Clare

Title: The Innovations of Jeffrey J Clare

Introduction

Jeffrey J Clare is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of biotechnology, particularly in the area of antigen production. With a total of 3 patents to his name, Clare's work has had a meaningful impact on medical research and applications.

Latest Patents

Clare's latest patents include groundbreaking work on the production of Bordetella pertactin antigens. His patent titled "Transformed Pichia expressing the pertactin antigen" focuses on the expression of these antigens in the methylotrophic yeast, Pichia. This innovation involves the use of expression vectors containing DNA encoding the antigens and Pichia transformants that contain one or more copies of the DNA encoding a pertactin antigen. Another significant patent is "Expression of tetanus toxin fragment C in yeast," which describes a method for expressing the tetanus toxin fragment C using a DNA coding sequence with an increased (G+C)-content. This enhancement allows for the production of complete mRNA transcripts, which is crucial for effective protein expression.

Career Highlights

Throughout his career, Jeffrey J Clare has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Evans Medical Limited and Medeva Pharma Limited. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work.

Collaborations

Clare has collaborated with esteemed colleagues, including Michael A Romanos and Neil F Fairweather. These partnerships have likely enriched his research and development efforts, leading to successful innovations.

Conclusion

Jeffrey J Clare's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in medical research and applications.